Introduction
============

β-crystallin B2 (CRYBB2) expression was initially reported in the eye lens where it functions to maintain lens transparency and refractive index. CRYBB2 deficiency was demonstrated to result in the generation of age-associated cataracts ([@b1-mmr-14-05-4223]). However, a number of previous studies demonstrated that CRYBB2 is also expressed in the retina, brain, testis, and ovary ([@b2-mmr-14-05-4223]--[@b5-mmr-14-05-4223]). Our previous study observed that CRYBB2 was expressed in human and mouse ovaries, particularly in ovarian granulosa cells ([@b6-mmr-14-05-4223]). *CRYBB2* knockout mice exhibited morphological and functional abnormalities in the ovary, including reduced ovarian index (ratio of ovary weight to total body weight) with increased follicle atresia, reduced mature follicles and dysregulated estrous cycle ([@b7-mmr-14-05-4223]). Our data from a previous study also indicated a high level of estrogen in the diestrus and metestrus, but a low level of progesterone in the metestrus compared with wild-type (WT) mice ([@b6-mmr-14-05-4223]). At the genetic level, expression of cell cycle and apoptosis-associated proteins, including B-cell lymphoma 2, cyclin-dependent kinase 4, and cyclin D2, were markedly lower in the *CRYBB2* knockout mice compared with WT mice ([@b6-mmr-14-05-4223]). These data suggest that *CRYBB2* may be important in ovary development, however, the underlying molecular mechanism by which *CRYBB2* regulates ovarian development remains to be elucidated.

To identify and assess the role of *CRYBB2* in ovary development, differentially expressed long non-coding RNAs (lncRNAs) were profiled in *CRYBB2* knockout mice. lncRNAs are a class of non-coding RNAs with nucleotides \>200 bp and transcribed by RNA polymerase II. Functionally, lncRNAs may regulate gene transcription, protein translation, and epigenetic modification of genomic DNA. Altered expression and regulation of lncRNAs has been associated with human diseases and aging ([@b8-mmr-14-05-4223]--[@b12-mmr-14-05-4223]). For example, previous studies have suggested that overexpression of lncRNA HOX transcript antisense RNA associated with the recurrence of hepatocellular carcinoma, poor prognosis in colorectal cancer, and malignant behaviors of gastrointestinal stromal tumors ([@b13-mmr-14-05-4223]--[@b15-mmr-14-05-4223]). lncRNAs modulate cell functions by regulating expression of targeted downstream genes ([@b16-mmr-14-05-4223]), which may in turn affect embryo development ([@b17-mmr-14-05-4223]), inactivate the X chromosome, and regulate genomic imprinting ([@b18-mmr-14-05-4223]). Thus, the current study assessed whether these lncRNAs mediate the functions of CRYBB2 in ovary development and investigated the underlying mechanisms. Microarray profiling between ovarian tissues from *CRYBB2* knockout and WT mice was conducted and bioinformatic analysis of differentially expressed lncRNAs and mRNAs was performed. A number of these differentially expressed lncRNAs and mRNAs were verified using quantitative reverse transcription-polymerase chain reaction (RT-qPCR).

Materials and methods
=====================

### Animals

Male and female C57BL/6 mice were obtained from the Experimental Animal Center of the Second Military Medical University (Shanghai, China). *CRYBB2* knockout mice were generated by the Ingenious Targeting Laboratory (Ronkonkoma, NY, USA), as described previously ([@b19-mmr-14-05-4223]). All mice were maintained on a 12 h light/dark cycle with a temperature of 21±1°C and humidity of 50\~70% in a pathogen-free facility with access to food and water *ad libitum*. Bedding material and a plastic house or tube was placed in the cage for environmental enrichment. Daily examinations were performed on all animals throughout the experimental period. Humane euthanasia of mice was performed under isoflurane anesthesia using intracardiac injection of pentobarbitone (150 mg/kg). The present study was conducted in accordance with institutional guidelines and approved by the Animal Care and Use Committee of Changhai Hospital (Shanghai, China).

A total of three 8-9-week-old (weight, 18.0±2.0 g) female *CRYBB2* knockout mice and three age-matched WT female mice were obtained. Ovary tissues were collected from mice following a 10-day experimental period.

### RNA isolation, cDNA synthesis and labeling, and hybridization

Ovarian tissues were homogenized on ice and total cellular RNA was isolated using TRIzol reagent (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA) according to the manufacturer\'s protocol and then quantified using NanoDrop ND-1000 (Thermo Fisher Scientific, Inc., Wilmington, DE, USA) and agarose gel electrophoresis. RNA samples were further purified using an RNeasy Mini kit (Qiagen, Inc., Valencia, CA, USA) and reverse transcribed into cDNA with fluorescent labeling for microarray hybridization using using the AffinityScript QPCR cDNA Synthesis kit (Agilent Technologies, Inc., Santa Clara, CA, USA). These labeled cDNA probes were then hybridized to Agilent mouse expression profiling (8×60K) microarray using the Gene Expression Hybridization kit (Agilent Technologies, Inc.) according to the manufacturer\'s protocol. The arrays were scanned into a file and analyzed using Feature Extraction software, version v10.7.3.1 (Agilent Technologies, Inc.). The arrays were scanned at 5 µm/pixel resolution using an Axon GenePix 4000B scanner (Molecular Devices, LLC, Sunnyvale, CA, USA) piloted by GenePix Pro 6.0 software (Molecular Devices, LLC) and then imported into NimbleScan software (version 2.5; Roche NimbleGen, Inc., Madison, WI, USA) for grid alignment and expression data analysis. Expression data were normalized using quantile normalization and the Robust Multichip Average algorithm included in the NimbleScan software. The probe level files and mRNA level files were generated following normalization. All mRNA level files were imported into Agilent GeneSpringGX software (version 11.0; Agilent Technologies, Inc.) for further analysis. Differentially expressed lncRNAs and mRNAs were identified via fold change filtering.

### Functional analysis of microarray data

Gene Ontology (GO; [www.geneontology.org](www.geneontology.org)) was performed to group differentially expressed lncRNAs and their targeted genes into biological processes, cellular components, and molecular features of the biological functions. Kyoto Encyclopedia of Genes and Genomes (KEGG; [www.genome.jp/kegg](www.genome.jp/kegg)) analysis was performed to identify roles of the target genes and group them into gene pathways. The correlation matrix method was used to establish a diagram of lncRNA and mRNA co-expression regulatory networks. Prior to functional analyses, the predicted potential lncRNA targets were integrated with the differentially expressed mRNAs using a cut-off value of ≥2.0 fold change or P\<0.05.

### RT-qPCR

Total RNA was isolated from granulosa cells from the ovaries of WT and *CRYBB2* knockout mice using TRIzol reagent and reverse transcribed into cDNA using the PrimeScript RT Reagent Kit (Takara Biotechnology, Co., Ltd., Dalian, China) according to the manufacturer\'s protocols. These cDNA samples were then subjected to qPCR analysis using a Applied Biosystems 7300 Real-Time PCR system (Applied Biosystems; Thermo Fisher Scientific, Inc.) with the SYBR Green PCR Master Mix kit (Takara Biotechnology, Co., Ltd.). qPCR amplification was conducted at 95°C for 2 min, followed by 40 cycles of 95°C for 15 sec, and 60°C for 30 sec. The relative expression of each target gene compared to β-actin was calculated using the 2^−ΔΔCq^ method ([@b20-mmr-14-05-4223]). Specific primers used were as follows: Forward, 5′-AGCCATGTACGTAGCCATCC-3′ and reverse, 5′-CTCTCAGCTGTGGTGGTGAA-3′ for β-actin; forward, 5′-CGAGTTGGTGCCAGTGTGGA-3′ and reverse, 5′-CCTGCTGTTGGTGGCCTCTT-3′ for *P2rx7*; and forward, 5′-TCCACTCAGGAAGAGCTGGT-3′ and reverse, 5′-TAGCACCCTCGGGATATCTG-3′ for lncRNAA-30-P01019163.

### Statistical analysis

All data were presented as the mean ± standard deviation. The data were Log2-transformed and median centered by genes using Cluster software, version 3.0 (<http://bonsai.hgc.jp/~mdehoon/software/cluster/software.htm>). Statistical analyses were performed using SPSS 17.0 (SPSS, Inc., Chicago, IL, USA). The data were statistically analyzed using an unpaired Student\'s *t*-test or by one-way analysis of variance followed by Tukey\'s test. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Microarray profiling of differentially expressed lncRNAs and mRNA in ovary tissues from wild type and CRYBB2 knockout mice

Microarray data on differential lncRNA and mRNA expression levels were analyzed using Cluster software, version 3.0 with the cut-off values set as ≥2-fold difference or P\<0.05. The data indicated 157 differentially expressed lncRNAs (42 downregulated vs. 115 upregulated) and 1,085 differentially expressed mRNAs (570 downregulated vs. 515 upregulated; [Fig. 1](#f1-mmr-14-05-4223){ref-type="fig"}). The genes were selected according to a software forecast associated with the processes of ovarian development, and the lncRNAs associated with these genes were selected ([Tables I](#tI-mmr-14-05-4223){ref-type="table"} and [II](#tII-mmr-14-05-4223){ref-type="table"}).

### Bioinformatic analysis of differentially expressed lncRNAs and mRNA in ovary tissues from WT and CRYBB2 knockout mice

GO analysis was performed for functional annotation of differentially expressed lncRNAs and mRNAs and it was observed that they were predominantly involved in cell cycle regulation, cell proliferation, metabolism, and signal transduction ([Table III](#tIII-mmr-14-05-4223){ref-type="table"}). One particular gene, P2rx7, localized in the cytoplasm, functions to regulate cell cycle progression and proliferation, and the signal transduction process.

Subsequently, KEGG analysis was conducted to group differentially expressed lncRNAs and mRNA into gene pathways. The data from the present study indicated that the genes predominantly formed signaling pathways associated with the regulation of Ca^2+^ signaling, ligand and receptor interactions, and other cell signaling pathways ([Table IV](#tIV-mmr-14-05-4223){ref-type="table"}). For example, P2rx7 was identified to be predominantly involved in Ca^2\ +^ signaling.

### Building the lncRNA-mRNA regulatory network

The lncRNA target predictions were superimposed into the lncRNA-mRNA correlation network. As presented in [Fig. 2](#f2-mmr-14-05-4223){ref-type="fig"}, the network has a total of 98 nodes, 75 connections, 53 lncRNAs and 45 mRNAs. Expression of glutathione S-transferase α 2 (Gsta2) and DEAD (Asp-Glu-Ala-Asp) box polypeptide 43 (Ddx43) was regulated by a total of five lncRNAs, while expression of coiled-coil domain containing 68 (Ccdc68), olfactory receptor 464 (Olfr464) and low density lipoprotein receptor-related protein 11 (Lrp11) were regulated by four lncRNAs. In addition, expression levels of protein kinase, cAMP dependent regulatory, type II β (Prkar2b), leucine-rich repeat-containing G protein-coupled receptor 6 (Lgr6) and adiponectin, C1Q and collagen domain containing (Adipoq) were regulated by a total of three lncRNAs.

### Validation of differentially expressed lncRNAs and mRNAs in ovary tissues of WT and CRYBB2 knockout mice

RT-qPCR analysis of different lncRNAs and mRNAs was performed and it was demonstrated that expression levels of lncRNA A-30-P01019163 and P2rx7 were significantly different between10 cases of ovary tissues from WT and *CRYBB2* knockout mice (P\<0.05; [Fig. 3](#f3-mmr-14-05-4223){ref-type="fig"}), whereas other lncRNAs and mRNAs did not indicate any difference between WT and *CRYBB2* knockout mouse ovary tissues (data not shown).

Discussion
==========

*CRYBB2* knockout mice exhibit abnormal morphological and functional mouse ovaries. The current study investigated the underlying molecular mechanisms by which *CRYBB2* affects expression of lncRNAs to alter mouse ovary structure and function. Certain aberrant lncRNA expression in the regulation of other genes was assessed. A total of 157 differentially expressed lncRNAs and 1,085 mRNAs were observed. The GO database analysis indicated that these altered gene expressions and were predominantly distributed in the biological process of metabolism, immune system, and signal transduction. The KEGG database pathway analysis suggested that the predominant signaling pathways were associated with Ca^2+^ signaling and ligand-receptor interaction.

Subsequent to establishing a correlation matrix lncRNA and mRNA co-expression network map, a total of 98 nodes, 75 connections, 53 lncRNAs, and 45 mRNAs were identified. Gsta2 and Ddx43 were regulated by five lncRNAs, Ccdc68, Olfr464 and Lrp11 by four lncRNAs, Prkar2b, Lgr6, and Adipoq by three lncRNAs. Gsta2 participates in cytochrome P450 metabolism and cytochrome P450 is important in the conversion of androgens to estrogens. P2rx7, Olfr464, Lrp11, Prkar2b, Lgr6, and Adipoq are involved in cellular signal transduction and P2rx7, Prkar2b, and Hdac1 are involved in regulation of the cell cycle and cell proliferation, while Prkar2b, Hdac1, and Dock7 are important in cell development. lncRNA A-30-P01019163 and P2rx7 were differentially expressed in ovarian tissues of *CRYBB2* knockout mice.

Crybb2 not only functions to maintain lens transparency and refractive index, but also affects ovary development in mice. At the gene level, Crybb2 may mediate Ca^2+^ signal transduction ([@b21-mmr-14-05-4223],[@b22-mmr-14-05-4223]). The current study demonstrated that Crybb2 also regulates expression of lncRNAs in ovarian tissues, which may be a novel area of research on Crybb2-regulation of gene expression. Previous studies using large scale cDNA library sequencing and next generation sequencing demonstrated abundant lncRNAs in mammals, however, not all lncRNAs are functional and only a relatively small proportion have been demonstrated to be biologically relevant ([@b11-mmr-14-05-4223],[@b23-mmr-14-05-4223]). For example, as of mid-2014, 197 lncRNAs have been functionally annotated in lncRNA databases ([@b24-mmr-14-05-4223]). However, other lncRNAs may be translated into proteins ([@b25-mmr-14-05-4223]). In addition, lncRNAs, unlike miRNAs, can down- or upregulate gene expression by targeting transcriptional activators or repressors ([@b10-mmr-14-05-4223]), in addition to post-transcriptional regulation of protein expression.

In the current study differentially expressed lncRNAs in ovary tissues of *CRYBB2* knockout mice were profiled and a total of 157 differentially expressed lncRNAs were observed. Furthermore, differentially expressed mRNAs were profiled and a total of 1,085 differentially expressed mRNAs in ovary tissues of *CRYBB2* knockout mice were observed. GO and KEGG pathway analyses were performed to determine associations between these lncRNAs and mRNAs, and a number of these were subsequently verified using RT-qPCR. It was observed that lncRNA A-30-P01019163 and P2rx7 were significantly differentially expressed between10 cases of ovary tissues from WT and *CRYBB2* knockout mice. Thus, *CRYBB2* knockout could downregulate expression of lncRNA A-30-P01019163 and, subsequently, suppress expression of the downstream gene P2rx7 and affect ovarian cell signal transduction, cell cycle, and ultimately ovarian development.

The current study is a proof-of-principle study and there are certain limitations. For example, it was not confirmed how lncRNA A-30-P01019163 regulates P2rx7 expression and the mechanistic investigation into how lncRNA A-30-P01019163-regulated P2rx7 expression mediates the effects of *CRYBB2* on ovary development could be expanded on.

In conclusion, CRYBB2 regulates expression of different lncRNAs to influence ovary development. lncRNA A-30-P01019163 may affect ovarian cell cycle and proliferation by regulating P2rx7 expression in the ovary.

The authors would like to thank Shanghai Sensichip Infotech Co., Ltd. (Shanghai, China) for assistance with bioinformatic analysis and Medjaden Bioscience Ltd. for assisting in the preparation of the manuscript. The present study was supported in part by grants from the National Natural Science Foundation of China (grant nos. 81170834 and 81300748).

![Cluster analysis of differentially expressed lncRNAs and mRNAs in ovary tissues from WT and β-crystallin B2 knockout mice. The horizontal axis represents the sample group and the vertical axis represents the differentially expressed mRNAs or lncRNAs. Upregulated genes are red and downregulated genes are green. Included are 157 lncRNAs (42 downregulated vs. 115 upregulated) and 1,085 mRNAs (570 downregulated vs. 515 upregulated) KO, knockout; WT, wild-type; lncRNA, long non-coding RNA.](MMR-14-05-4223-g00){#f1-mmr-14-05-4223}

![lncRNA-mRNA regulatory network. Circles represent genes and triangles represent lncRNAs; lines represent the association between the two types of regulation (solid line represents a *cis*-regulation, the dashed line represents the *trans*-regulation). lncRNA, long non-coding RNA.](MMR-14-05-4223-g01){#f2-mmr-14-05-4223}

![Validation of differentially expressed lncRNAs and mRNAs in ovary tissues from WT and *CRYBB2* knockout mice. (A) RT-qPCR indicated lncRNA A-30-P01019163 was downregulated in ovary tissues from *CRYBB2* KO mice; (B) RT-qPCR indicated P2rx7 was downregulated in ovary tissues from the *CRYBB2* KO mice. \*P\<0.05. RT-qPCR, reverse transcription-quantitative polymerase chain reaction; KO, knock out; WT, wild-type.](MMR-14-05-4223-g02){#f3-mmr-14-05-4223}

###### 

Differentially expressed long non-coding RNAs in ovary tissues from β-crystallin B2 knockout mice.

  Probe name       P-value       FC (abs)    Regulation
  ---------------- ------------- ----------- ------------
  A_30_P01032506   0.001900622   2.244835    Down
  A_30_P01029732   0.026376737   2.3413253   Down
  A_30_P01020038   0.020382054   2.3550973   Down
  A_30_P01019163   0.008867065   2.3823233   Down
  A_30_P01017808   0.003141625   2.3902857   Down
  A_30_P01028465   0.026580842   2.3909771   Down
  A_30_P01024278   0.010205811   2.4727218   Down
  A_30_P01031572   0.036648612   2.5956807   Down
  A_30_P01027590   0.034441914   2.6343288   Down
  A_30_P01022135   0.04770927    3.120179    Down
  A_30_P01031631   0.001265911   3.135137    Down
  A_30_P01032372   0.009654216   3.4001627   Down
  A_30_P01032133   0.012271924   3.434039    Down
  A_30_P01024342   2.97×10^−4^   3.7296832   Down
  A_30_P01024108   0.004697592   3.8198798   Down
  A_30_P01022445   2.66×10^−5^   3.8623033   Down
  A_30_P01022656   2.08×10^−4^   4.069888    Down
  A_30_P01023636   0.02164327    4.4273615   Down
  A_30_P01022538   9.77×10^−4^   5.492365    Down
  A_30_P01033546   0.004913332   5.9940124   Down
  A_30_P01019023   0.024659809   3.7894382   Up
  A_30_P01024108   0.004697592   3.8198798   Up
  A_30_P01017880   0.034943227   3.8256395   Up
  A_30_P01022445   2.66×10^−5^   3.8623033   Up
  A_30_P01026472   0.022304738   3.8728366   Up
  A_30_P01030900   0.023211088   3.9997435   Up
  A_30_P01022656   2.08×10^−4^   4.069888    Up
  A_30_P01018745   1.84×10^−5^   4.266393    Up
  A_30_P01033353   0.03583063    4.398616    Up
  A_30_P01021636   0.01934708    4.4207296   Up
  A_30_P01023636   0.02164327    4.4273615   Up
  A_30_P01022538   9.77×10^−4^   5.492365    Up
  A_30_P01019825   0.006051722   5.5902176   Up
  A_30_P01033546   0.004913332   5.9940124   Up
  A_30_P01024788   1.11×10^−5^   7.118162    Up
  A_30_P01024270   6.38×10^−5^   8.226261    Up
  A_30_P01027087   0.003292078   8.981714    Up
  A_30_P01031162   0.011685452   9.579193    Up
  A_30_P01021698   1.31×10^−5^   10.52238    Up
  A_30_P01020936   4.52×10^−4^   22.788074   Up

FC, fold change.

###### 

Differentially expressed mRNAs in ovary tissues from β-crystallin B2 knockout mice.

  Gene      P-value       FC (abs)    Regulation
  --------- ------------- ----------- ------------
  Prkar2b   0.040216      2.1857524   Down
  Lrp11     0.006975      2.9040618   Down
  P2rx7     4.11×10^−4^   4.6213336   Down
  Calml3    0.011701      5.126569    Down
  Dclre1c   3.39×10^−4^   5.1453366   Down
  Lpcat2    0.002695      5.828531    Down
  Stk32a    0.001242      5.833555    Down
  Cyp19a1   0.034041      6.1799      Down
  Megf10    0.045621      6.1827664   Down
  Plcxd1    1.04×10^−4^   6.82413     Down
  Gm5103    0.005622      8.389297    Down
  Fermt1    0.001363      8.656997    Down
  Mlxip     3.10×10^−4^   8.746344    Down
  Slc6a2    0.046581      8.750824    Down
  Gm7969    0.012795      9.970471    Down
  Ces2a     0.028129      10.472376   Down
  Dclre1c   1.23×10^−4^   10.645219   Down
  Ostn      9.07×10^−6^   11.019576   Down
  Jph4      0.001674      12.722166   Down
  Onecut2   0.048542      13.894124   Down
  Ces2a     0.028128909   10.472376   Up
  Dclre1c   1.23×10^−4^   10.645219   Up
  Jph4      0.001673621   12.722166   Up
  Onecut2   0.04854157    13.894124   Up
  Itln1     5.97×10^−5^   14.339393   Up
  Arsk      7.13×10^−5^   16.06716    Up
  Sfrp4     0.023781205   17.065975   Up
  Plekhg4   0.047409292   17.067673   Up
  Nuf2      6.05×10^−5^   17.872303   Up
  Adh7      0.0064019     18.950857   Up
  Itln1     4.63×10^−5^   19.05549    Up
  Ptgfr     0.032550577   20.059986   Up
  Pou6f1    1.71×10^−4^   23.766891   Up
  Saa2      0.023944996   25.063555   Up
  Wnt10b    0.02046059    27.648937   Up
  Ifi202b   0.001051159   28.72067    Up
  Dcpp1     0.014649089   40.37458    Up
  Cd5l      4.12×10^−4^   42.74245    Up
  Dcpp2     0.012848383   45.13117    Up

FC, fold change.

###### 

Gene ontology analysis of differentially expressed genes.

  Term                                  Number of genes (%)   P-value
  ------------------------------------- --------------------- ----------
  Biological process                                          
    Cell cycle and proliferation          3 (4)               0.479979
    Stress response                       4 (6)               0.205102
    Transport                             5 (7)               0.563981
    Developmental processes               6 (9)               0.459856
    RNA metabolism                        7 (10)              0.315857
    Other metabolic processes           12 (17)               0.007676
    Cell organization and biogenesis      6 (9)               0.193590
    Cell-cell signaling                   1 (1)               0.502761
    Signal transduction                   11 (16)             0.120754
    Protein metabolism                    6 (9)               0.502818
    Death                                 1 (1)               0.827556
    Other biological processes            8 (11)              0.990425
  Cellular component                                          
    Cytosol                               1 (2)               0.505969
    Mitochondrion                         1 (2)               0.862146
    Endoplasmic reticulum/golgi           3 (5)               0.460760
    Other cytoplasmic organelle           1 (2)               0.604395
    Nucleus                             10 (18)               0.306385
    Plasma membrane                       6 (1)               0.438812
    Other membranes                     14 (26)               0.661329
    Translational apparatus               1 (2)               0.330956
    Non-structural extracellular          2 (4)               0.830334
    Other cellular component            15 (28)               0.354726
  Molecular function                                          
    Enzyme regulator activity             3 (5)               0.141417
    Transcription regulatory activity     4 (7)               0.174629
    Transporter activity                  2 (4)               0.623057
    Signal transduction activity        11 (20)               0.082302
    Nucleic acid binding activity         7 (13)              0.252320
    Kinase activity                       2 (4)               0.503159
    Other molecular function            26 (47)               0.535279

###### 

KEGG pathways analysis of differentially expressed genes.

  Term                                           Count   P-value    Genes                         Up   Down
  ---------------------------------------------- ------- ---------- ----------------------------- ---- ------
  Glutathione metabolism                         1       0.106032   Gsta2                         0    1
  Metabolism of xenobiotics by cytochrome P450   1       0.143567   Gsta2                         0    1
  Drug metabolism-cytochrome P450                1       0.147434   Gsta2                         0    1
  Ribosome                                       1       0.172182   Rps3a                         0    1
  PPAR signaling pathway                         1       0.143567   Adipoq                        0    1
  Calcium signaling pathway                      3       0.00614    P2rx7, Ptger1, Ptafr          3    0
  Cytokine-cytokine receptor interaction         1       0.45143    Cxcl1                         0    1
  Chemokine signaling pathway                    1       0.353888   Cxcl1                         0    1
  Neuroactive ligand-receptor interaction        4       0.001745   P2rx7, Ptger1, Ptafr, Vipr1   4    0
  Cell cycle                                     1       0.226819   Hdac1                         0    1
  Apoptosis                                      1       0.179664   Prkar2b                       1    0
  Notch signaling pathway                        1       0.099971   Hdac1                         0    1
  Insulin signaling pathway                      1       0.268146   Prkar2b                       1    0
  Adipocytokine signaling pathway                1       0.139685   Adipoq                        0    1
  Type II diabetes mellitus                      1       0.099971   Adipoq                        0    1
  Huntington\'s disease                          1       0.334126   Hdac1                         0    1
  Pathways in cancer                             1       0.530933   Hdac1                         0    1
  Chronic myeloid leukemia                       1       0.155119   Hdac1                         0    1
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